These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22264050)

  • 1. Formulation and delivery of microbicides.
    Agashe H; Hu M; Rohan L
    Curr HIV Res; 2012 Jan; 10(1):88-96. PubMed ID: 22264050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of the vaginal delivery route for antiretrovirals in HIV prevention.
    Ferguson LM; Rohan LC
    Ther Deliv; 2011 Dec; 2(12):1535-50. PubMed ID: 22468220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.
    Forbes CJ; McCoy CF; Murphy DJ; Woolfson AD; Moore JP; Evans A; Shattock RJ; Malcolm RK
    J Pharm Sci; 2014 May; 103(5):1422-32. PubMed ID: 24585370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An algorithm for the preclinical development of anti-HIV topical microbicides.
    Buckheit RW; Buckheit KW
    Curr HIV Res; 2012 Jan; 10(1):97-104. PubMed ID: 22264051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo models of HIV sexual transmission and microbicide development.
    Ariën KK; Kyongo JK; Vanham G
    Curr HIV Res; 2012 Jan; 10(1):73-8. PubMed ID: 22264048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and delivery of anti-HIV rectal microbicides: advances and challenges.
    Nunes R; Sarmento B; das Neves J
    J Control Release; 2014 Nov; 194():278-94. PubMed ID: 25229988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
    Sidibe S; Pack AP; Tolley EE; Ryan E; Mackenzie C; Bockh E; Githuka G
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19151. PubMed ID: 25224612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current State of Microbicide Development.
    Traore YL; Chen Y; Ho EA
    Clin Pharmacol Ther; 2018 Dec; 104(6):1074-1081. PubMed ID: 30107032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Antiretroviral Microbicides for HIV Prevention.
    Scott Y; Dezzutti CS
    AIDS Rev; 2016; 18(3):145-150. PubMed ID: 27438574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models for microbicide studies.
    Veazey RS; Shattock RJ; Klasse PJ; Moore JP
    Curr HIV Res; 2012 Jan; 10(1):79-87. PubMed ID: 22264049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal microbicides and their delivery platforms.
    D'Cruz OJ; Uckun FM
    Expert Opin Drug Deliv; 2014 May; 11(5):723-40. PubMed ID: 24506783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community and research staff collaboration for development of materials to inform microbicide study participants in Africa.
    Woodsong C; Mutsambi JM; Ntshele S; Modikoe P
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19156. PubMed ID: 25224615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal microbicides and the prevention of HIV transmission.
    Cutler B; Justman J
    Lancet Infect Dis; 2008 Nov; 8(11):685-97. PubMed ID: 18992405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of microbicide formulations.
    Morrow KM; Hendrix C
    Antiviral Res; 2010 Dec; 88 Suppl 1(Suppl 1):S40-6. PubMed ID: 21109067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention.
    Wang L; Sassi AB; Patton D; Isaacs C; Moncla BJ; Gupta P; Rohan LC
    Drug Dev Ind Pharm; 2012 Aug; 38(8):995-1007. PubMed ID: 22149387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
    Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.